Cellectar Biosciences Inc. – Filings and Transcripts

NASDAQ: CLRB
Share price (3/24/26): $3.01
Market cap (3/24/26): $12.8 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Prospectus supplement

Initial registration of new securities

Prospectus supplement with pricing info

Initial registration of new securities – amended

Initial registration of new securities

Ownership Filter

Bleichroeder LP

Rosalind Advisors, Inc.

Hexstone Capital LLC

Bleichroeder LP

News Filter

Reports Financial Results for Year Ended 2025 and Provides Corporate Updates

Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Material Definitive Agreement, Earnings Release or Operating Update, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Other Events, Financial Statements or Exhibits

Announces European Medicines Agency (EMA) Confirms Eligibility to File for Conditional Marketing Authorization (CMA) for Iopofosine I 131 as a Treatment for Refractory (Post-BTKi) Waldenstrom Macroglobulinemia

Reports Second Quarter 2025 Financial Results and Provides a Corporate Update

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission